Paul G. Thomas
Independent Chairman of the BoardMr. Paul G. Thomas is Independent Director of TELA Bio, Inc. He serves as Independent Director at AxoGen, Inc. since September 30, 2020 and also serves as its Chairman of the Board since August 09, 2024. He serves as CEO, Co-Founder and Director at Prominex, Inc. He founded Sorrento Tech, Inc. in September 2009 and served as its Chief Executive Officer and President from September 2009 to January 2017. He has served as the Co-Founder and Chief Executive Officer of Prominex, Inc. since January 2018. Mr. Thomas has extensive leadership experience with companies in the life science industry and has an extensive background leading biotechnology companies, particularly through a variety of successful financial transactions. He has experience in the medtech industry. He served as the Executive Chairman of LifeCell Corporation from October 1998 to 2008 and served as its Chief Executive Officer and President from October 1998 to August 2008. Prior to joining LifeCell, he held various senior positions with Ohmeda, Inc. (Now Baxter PPD), including as the President of its Pharmaceutical Products Division, President and Chief Operating Officer. During his tenure at Sorrento Tech, Inc., he led the spinout of en-Probe s technology assets into a new independent company with financial sponsorship from private equity firms including Orbimed Advisors, New Enterprise Associates and TPG Biotech. He has served as Chairman of Sorrento Tech, Inc. since January 2017 until his retirement in January 2017 and has served as its Director since September 2009 until his retirement in January 2017. Prior to Prominex, he served asFounder, Chief Executive Officer and President of Roka Bioscience, Inc., a moleculardiagnostics company focused on food safety applications, from September 2009 until January 2017. He served as an Executive Director of LifeCell Corporation from October 1998 to May 2008. He serves as the Chairman of Innovative Spinal Technologies, Inc. He serves as Director at Surgalign Spine Technologies, Inc. He has been a Director of Surgalign Holdings, Inc. since June 2016 and Cohera Medical, Inc. since July 25, 2016. He had been a Director of ABIOMED, Inc. since May 2011 until December 22, 2022. He served as Director of Aegerion Pharmaceuticals, Inc. from August 1, 2011 to November 29, 2016. He served as a Director of BioNJ Inc. He served as a Director of Orthovita Inc., from July 27, 2007 to July 27, 2011. He served as an Independent Outside Director at Avanir Pharmaceuticals, Inc. since March 17, 2005. He received his MBA in Finance and Marketing from Columbia University Graduate School of Business and completed his postgraduate studies in chemistry at the University of Georgia Graduate School of Arts and Sciences. He received his B.S. in Chemistry from St. Michael's College in Vermont.
Positions
- Company NameAxogen, Inc.Stock CodeAXGNPositionIndependent Chairman of the BoardColleagues
- MDMichael D. DalePresident, CEO & Director
- PGPaul G. ThomasIndependent Chairman of the Board
- LHLindsey HartleyChief Financial Officer
- EDErick DeVinneyChief Scientific Officer
- MAMarc A. BeganExecutive VP, General Counsel, Secretary & Chief Compliance Officer
- JSJens Schroeder KempChief Marketing Officer
- JHJohn H. JohnsonIndependent Director
- WPWilliam P. BurkeIndependent Director
- KWKathy WeilerIndependent Director
- Company NameTELA Bio, Inc.Stock CodeTELAPositionIndependent DirectorColleagues
- JBJeffrey BlizardPresident
- JHJoseph H. CapperIndependent Chairman
- HCHeather C. GetzCEO, Principal Financial Officer & Director
- MFMike FarrellSenior Vice President of Finance
- MSMegan SmeykalVP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
- PTPaul TalmoChief Science & Innovation Officer
- WJWilliam John PlovanicIndependent Director
- GPGuy Paul NohraIndependent Director
